Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis

Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has significantly expanded its DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical DMPK, quantitative bioanalysis, in vitro pharmacology and expert interpretation. This latest acquisition by Sygnature – which has in...

PHARMASEAL’s £1million crowdfunding campaign gains momentum

A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone. Launched by the new provider of clinical trial management and governance solutions last month, the campaign is aimed at raising capital in order to continue its journey using...

Applications closing soon for ABHI US Accelerator 2021 cohort

Looking to do Business in the World’s Largest HealthTech Market? Applications closing soon for ABHI US Accelerator 2021 cohort. UK HealthTech companies looking to strengthen and grow their US activities are encouraged to apply now for the Association of British HealthTech Industries (ABHI) US Accelerator 2021 cohort. The final closing date...

Olberon’s Novel Products Attracting Interest Around the World

Nottingham medical device company, Olberon Ltd, are experiencing significant interest for its existing and pipeline products despite the COVID 19 pandemic. The company, founded by Dr Arash Bakhtyari, a Nottingham Radiologist, develop and commercialise innovative medical device concepts that originate from direct experience of patient care. Dr Bakhtyari explained “This...

Deloitte to launch health tech innovation hub

Deloitte is launching a Health Tech Catalyst in Birmingham that will be a collaborative platform for those responsible for developing, or investing in digital solutions for frontline care. Its aim is to accelerate health tech innovation in the Midlands and beyond, which could ultimately improve people’s health and wellbeing. The decision to...

Spirit Digital enables re-introduction of Cardiopulmonary Rehabilitation services through its remote monitoring platform, CliniTouch Vie

Spirit Digital today announces that CCGs across the UK whose Cardiopulmonary Rehabilitation services were suspended during COVID-19 will be able to restart these services supported by its digital, remote monitoring platform, CliniTouch Vie. As the government aims to substantially increase referral rates, CliniTouch Vie will enable clinical teams to remotely...